ATI RN
ATI Exit Exam RN
1. A client with asthma is prescribed a corticosteroid inhaler. Which of the following instructions should the nurse include?
- A. Use the inhaler as needed for acute symptoms.
- B. Rinse the mouth after each use.
- C. Take the medication only during asthma attacks.
- D. Administer a bronchodilator after using the corticosteroid.
Correct answer: B
Rationale: The correct instruction is to rinse the mouth after each use of a corticosteroid inhaler to prevent oral candidiasis (thrush). Choice A is incorrect because corticosteroid inhalers are usually used on a regular schedule to control asthma symptoms, not just for acute symptoms. Choice C is incorrect as corticosteroid inhalers are typically used for long-term management, not just during asthma attacks. Choice D is incorrect as administering a bronchodilator after using a corticosteroid is not a standard practice and is not necessary for the effectiveness of the corticosteroid inhaler.
2. A nurse is assessing a client who has diabetes mellitus and is experiencing hypoglycemia. Which of the following findings should the nurse expect?
- A. Tachycardia
- B. Dry mouth
- C. Diaphoresis
- D. Increased appetite
Correct answer: C
Rationale: The correct answer is C: Diaphoresis. Diaphoresis, which is excessive sweating, is a common sign of hypoglycemia due to the activation of the sympathetic nervous system. Tachycardia (choice A) is more commonly associated with hyperglycemia. Dry mouth (choice B) is not a typical finding in hypoglycemia but may be seen in hyperglycemia. Increased appetite (choice D) is not a typical sign of hypoglycemia and is more commonly associated with hyperglycemia.
3. A healthcare professional is reviewing laboratory results for a client who has cirrhosis. Which of the following findings should the professional report to the provider?
- A. Albumin 3.5 g/dL
- B. Bilirubin 1.0 mg/dL
- C. INR 3.0
- D. Ammonia 80 mcg/dL
Correct answer: C
Rationale: An INR of 3.0 is elevated, indicating impaired blood clotting function, which poses a significant risk of bleeding in clients with cirrhosis. This finding should be promptly reported to the provider for further evaluation and management. Choice A (Albumin 3.5 g/dL) is within the normal range and indicates adequate liver synthetic function, so it does not require immediate reporting. Choice B (Bilirubin 1.0 mg/dL) is also within the normal range and typically seen in clients without significant liver dysfunction, so it does not need urgent attention. Choice D (Ammonia 80 mcg/dL) is elevated, but it is not the priority finding in cirrhosis; elevated ammonia levels are associated with hepatic encephalopathy rather than increased bleeding risk.
4. A nurse is reviewing the medical record of a client who is 24 hours postoperative following abdominal surgery. Which of the following findings should the nurse report to the provider?
- A. Heart rate 90/min
- B. Serosanguineous drainage in the surgical drain
- C. Temperature 38.6°C (101.5°F)
- D. Urinary output 60 mL/hr
Correct answer: C
Rationale: The correct answer is C. A temperature of 38.6°C (101.5°F) is above the normal range and indicates a fever, which is a concerning finding postoperatively. Fever can be a sign of infection, so the nurse should report this finding to the provider for further evaluation and intervention. Choices A, B, and D are within expected parameters for a client who is 24 hours postoperative following abdominal surgery and do not require immediate reporting. A heart rate of 90/min, serosanguineous drainage in the surgical drain, and a urinary output of 60 mL/hr are all common postoperative findings that do not raise immediate concerns.
5. A healthcare provider is reviewing the medical record of a client who has schizophrenia and is taking clozapine. Which finding should the healthcare provider identify as a contraindication to the administration of clozapine?
- A. Heart rate 58/min.
- B. Fasting blood glucose 100 mg/dL.
- C. Hgb 14 g/dL.
- D. WBC count 2,900/mm3.
Correct answer: D
Rationale: The correct answer is D: a low WBC count. Clozapine can suppress bone marrow function, leading to a decreased white blood cell count. This condition, known as agranulocytosis, increases the risk of severe infections. Monitoring WBC counts is essential during clozapine therapy. Choices A, B, and C are within normal ranges and are not contraindications for administering clozapine.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access